Complication of warfarin therapy presenting as empyema
- PMID: 22263065
- PMCID: PMC3256491
- DOI: 10.3978/j.issn.2072-1439.2010.11.8
Complication of warfarin therapy presenting as empyema
Abstract
A number of risk indices have been formulated in an attempt to predict risk of a major hemorrhage in an individual on warfarin therapy. No single index to date is able to reliably predict this risk in an individual patient. Although most warfarin related hemorrhages are gastrointestinal or intracranial in origin this case represents a particularly rare entity of a major hemorrhage presenting as an encysted empyema. To the best of our knowledge this has never before been described.
Keywords: empyema; hematology; lung; thoracotomy..
Figures
References
-
- Kucher N, Connolly S, Beckman JA, Cheng LH, Tsilimingras KV, Fanikos J, et al. International normalized ratio increase before warfarin-associated hemorrhage: brief and subtle. Arch Intern Med. 2004;164:2176–9. - PubMed
-
- Hylek EM, Chang YC, Skates SJ, Hughes RA, Singer DE. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. Arch Intern Med. 2000;160:1612–7. - PubMed
-
- Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med. 1998;105:91–9. - PubMed
-
- Kuijer PM, Hutten BA, Prins MH, Büller HR. Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism. Arch Intern Med. 1999;159:457–60. - PubMed
Publication types
LinkOut - more resources
Full Text Sources